Solid self-nanoemulsifying drug delivery system (S-SNEDDS) for oral delivery of glimepiride: Development and antidiabetic activity in albino rabbits

Drug Delivery

Volumn 22, Issue 4, 2015, Pages 499-508

  Mohd, Abdul Bari ^a   Sanka, Krishna ^a   Bandi, Srikanth ^a   Diwan, Prakash V ^a   Shastri, Nalini ^b  

^a ANURAG UNIVERSITY   (India)

^b NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

Author keywords

Aerosol 200; dissolution; glimepiride; oral delivery; S SNEDDS; solid carrier

Indexed keywords

AEROSIL; CAPRIC TRIGLYCERIDE; COTTON SEED OIL; CREMOPHOR; EXCIPIENT; GLIMEPIRIDE; GLUCOSE; MACROGOL 400; OLEIC ACID; POLYSORBATE 80; POTASSIUM DIHYDROGEN PHOSPHATE; PROPYLENE GLYCOL; SORBITAN LAURATE; SORBITAN OLEATE; SOYBEAN OIL; UNCLASSIFIED DRUG; ANTIDIABETIC AGENT; EMULSION; GLUCOSE BLOOD LEVEL; SULFONYLUREA DERIVATIVE;

ALBINO RABBIT; ANIMAL EXPERIMENT; ANTIDIABETIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG RELEASE; DRUG SOLUBILITY; GLUCOSE BLOOD LEVEL; IN VITRO STUDY; MALE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; SOLID SELF NANOEMULSIFYING DRUG DELIVERY SYSTEM; SOLID STATE; SUSPENSION; X RAY POWDER DIFFRACTION; ANIMAL; CHEMISTRY; COMPARATIVE STUDY; DRUG EFFECTS; EMULSION; ORAL DRUG ADMINISTRATION; RABBIT; SOLUBILITY; X RAY DIFFRACTION;

ADMINISTRATION, ORAL; ANIMALS; BLOOD GLUCOSE; CALORIMETRY, DIFFERENTIAL SCANNING; DRUG DELIVERY SYSTEMS; DRUG LIBERATION; EMULSIONS; HYPOGLYCEMIC AGENTS; MALE; MICROSCOPY, ELECTRON, SCANNING; PARTICLE SIZE; RABBITS; SOLUBILITY; SULFONYLUREA COMPOUNDS; X-RAY DIFFRACTION;

EID: 84933510049     PISSN: 10717544     EISSN: 15210464     Source Type: Journal    
DOI: 10.3109/10717544.2013.879753     Document Type: Article

References (52)

1. Allaboun H, Alkhamis KA, AlMomani WY. (2003). The application of the convective diffusion model and the film equilibrium model to surfactant-facilitated dissolution of gliclazide. Eur J Pharm Sci 19:231-6.
2. Amidon GL, Lennernäs H, Shah VP, Crison JR. (1995). A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res 12:413-20.
3. Ammar HO, Salama HA, Ghorab M, Mahmouda AA. (2006). Implication of inclusion complexation of glimepiride in cyclodextrin-polymer systems on its dissolution, stability and therapeutic efficacy. Int J Pharm 320:53-7.
4. Badr-Eldin SM, Elkheshen SA, Ghorab MM. (2008). Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation. Eur J Pharm Biopharm 70:819-27.
5. Balakrishnan A, Rege BD, Amidon GL, Polli JE. (2004). Surfactant-mediated dissolution: contributions of solubility enhancement and relatively low micelle diffusivity. J Pharm Sci 93:2064-75.
6. Balakrishnan P, Lee BJ, Oh DH, et al. (2009). Enhanced oral bioavailability of dexibuprofen by a novel solid Self-emulsifying drug delivery system (SEDDS). Eur J Pharm Biopharm 72:539-45.
7. Bannwart B, Bertin P, Péhourcq F, et al. (2001). Piroxicam concentrations in plasma and synovial fluid after a single dose of piroxicambeta-cyclodextrin. Int J Clin Pharmacol Ther 39:33-6.
8. Bayindir ZS, Yuksel N. (2010). Characterization of niosomes prepared with various nonionic surfactants for paclitaxel oral delivery. J Pharm Sci 99:2049-60.
9. Beg S, Swain S, Rizwan Md, et al. (2011). Bioavailability enhancement strategies: basics, formulation approaches and regulatory considerations. Curr Drug Deliv 8:1-12.
10. Burcin Y, Erem B, Imran V, Murat S. (2010). Alternative oral exemestane formulation: improved dissolution and permeation. Int J Pharm 398:137-45.
11. Carrier RL, Miller LA, Ahmed I. (2007). The utility of cyclodextrins for enhancing oral bioavailability. J Control Release 123:78-99.
12. Chadha R, Saini A, Arora P, Bhandari S. (2012). Pharmaceutical cocrystals: a novel approach for oral bioavailability enhancement of drugs. Crit Rev Ther Drug Carrier Syst 29:183-218.
13. Chakraborty S, Shukla D, Jain A, et al. (2009). Assessment of solubilization characteristics of different surfactants for carvedilol phosphate as a function of pH. J Colloid Interface Sci 335:242-449.
14. Date AA, Nagarsenker MS. (2007). Design and evaluation of self-nanoemulsifying drug delivery systems (SNEDDS) for cefpodoxime proxetil. Int J Pharm 329:166-72.
15. Gamsiz ED, Miller L, Thombre AG, et al. (2010a). Modeling the influence of cyclodextrins on oral absorption of low solubility drugs: II. Experimental validation. Biotechnol Bioeng 105:421-30.
16. Gamsiz ED, Miller L, Thombre AG, et al. (2010b). Modeling the influence of cyclodextrins on oral absorption of low-solubility drugs: I. Model development. Biotechnol Bioeng 105:409-20.
17. Gamsiz ED, Thombre AG, Ahmed I, Carrier RL. (2011). Drug salts and solubilization: modeling the influence of cyclodextrins on oral absorption. Ann Biomed Eng 39:455-68.
18. Girish SS, Devendra KJ, Dhananjay MM. (2007). Preparation and in vitro evaluation of bilayer and floating bioadhesive tablets of rosiglitazone maleate. Asian J Pharm Sci 2:161-9.
19. Grunenberg A, Keil B, Henck JO. (1995). Polymorphism in binary mixtures, as exemplified by nimodipine. Int J Pharm 118:11-21.
20. Jain SK, Awasthi AM, Jain NK, Agrawal GP. (2005). Calcium silicate based microspheres of repaglinide for gastro retentive floating drug delivery: preparation and in vitro characterization. J Control Release 107:300-9.
21. Jin Y, Wen J, Garg S, et al. (2013). Development of a novel niosomal system for oral delivery of Ginkgo biloba extract. Int J Nanomed 8: 421-30.
22. Khazaeli P, Pardakhty A, Shoorabi H. (2007). Caffeine-loaded niosomes: characterization and in vitro release studies. Drug Deliv 14:447-52.
23. Krutika K. Sawant, Shweta Guptha, Sandip Chavhan. (2011). Self-nanoemulsifying drug delivery system for Adefovir dipivoxil: design, characterization, in vitro and ex vivo evaluation. Colloids Surf A 392: 145-55.
24. Kumar N, Shishu, Bansal G, et al. (2013). Preparation and cyclodextrin assisted dissolution rate enhancement of itraconazolium dinitrate salt. Drug Dev Ind Pharm 39:342-51.
25. Kyatanwar AU, Gajbhiye ND, Jadhav KR, Kadam VJ. (2010). Solid self emulsifying drug delivery system: a review. J Pharm Res 3: 877-82.
26. Li S, Wong S, Sethia S, et al. (2005). Investigation of solubility and dissolution of a free base and two different salt forms as a function of pH. Pharm Res:628-35.
27. Lobenberg R, Amidon GL. (2000). Modern bioavailability, bioequivalence and biopharmaceutics classification system. New scientific approaches to international regulatory standards. Eur J Pharm Biopharm 50:3-12.
28. Manconi M, Nácher A, Merino V, et al. (2013). Improving oral bioavailability and pharmacokinetics of liposomal metformin by glycerolphosphate-chitosan microcomplexation. AAPS Pharm Sci Tech 14:485-96.
29. Miyake K, Arima H, Hirayama F, et al. (2000). Improvement of solubility and oral bioavailability of rutin by complexation with 2-hydroxypropyl-beta-cyclodextrin. Pharm Dev Technol 5: 399-407.
30. Nazzal S, Guven N, Reddy IK, Khan MA. (2002a). Preparation and characterization of coenzyme QlO-Eudragit solid dispersion. Drug Dev Ind Pharm 28:49-57.
31. Nazzal S, Smalyukh II, Lavrentovich OD, Khan MA. (2002b). Preparation and in vitro characterization of a eutectic based semisolid self nanoemulsified drug delivery system (SNEDDS) of ubiquinone: mechanism and progress of emulsion formation. Int J Pharm 235: 247-65.
32. Oh DH, Kang JH, Kim DW, et al. (2011). Comparison of solid self-microemulsifying drug delivery system (solid SMEDDS) prepared with hydrophilic and hydrophobic solid carrier. Int J Pharm 420: 412-8.
33. Patravale VB, Date AA, Kulkarni RM. (2004). Nanosuspensions: a promising drug delivery strategy. J Pharm Pharmacol 56:827-40.
34. Pouton CW. (2000). Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and 'self-microemulsifying' drug delivery systems. Eur J Pharm Sci 11:S93-8.
35. Pouton CW. (2006). Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system. Eur J Pharm Sci 29: 278-87.
36. Qiao N, Li M, Schlindwein W, et al. (2011). Pharmaceutical cocrystals: an overview. Int J Pharm 419:1-11.
37. Sandya RT, Sujatha S, Veeresham C. (2012). Pharmacokinetic and pharmacodynamic interaction of curcumin with glimepiride in normal and diabetic rats. Phcog Commn 2:14-21.
38. Serajuddin AT. (2007). Salt formation to improve drug solubility. Adv Drug Deliv Rev 59:603-16.
39. Serajuddin TM. (1999). Solid dispersion of poorly water-soluble drugs: early promises, subsequent problems, and recent breakthroughs. J Pharm Sci 88:1058-66.
40. Setthacheewakul S, Mahattanadul S, Phadoongsombut N, et al. (2010). Development and evaluation of self-microemulsifying liquid and pellet formulations of curcumin, and absorption studies in rats. Eur J Pharm Biopharm 76:475-85.
41. Sezgin-Bayindir Z, Onay-Besikci A, Vural N, Yuksel N. (2013). Niosomes encapsulating paclitaxel for oral bioavailability enhancement: preparation, characterization, pharmacokinetics and biodistribution. J Microencapsul, [Epub ahead of print]. Pages 1-9.
42. Shan N, Zaworotko MJ. (2008). The role of cocrystals in pharmaceutical science. Drug Discov Today 13:440-6.
43. Shanmugam S, Baskaran R, Balakrishnan P, et al. (2011). Solid self-nanoemulsifying drug delivery system (S-SNEDDS) containing phosphatidylcholine for enhanced bioavailability of highly lipophilic bioactive carotenoid lutein. Eur J Pharm Biopharm 79:250-7.
44. Shweta G, Sandip C, Krutika KS. (2011). Self-nanoemulsifying drug delivery system for adefovir dipivoxil: design, characterization, in vitro and ex vivo evaluation. Colloid Surf A 392:145-55.
45. Srinivas M, Krishna S, Prabhakar RV. (2011). Design and evaluation of hydrochlorthiazide gastroretentive floating drug delivery system. Asian J Pharm Sci 6:208-17.
46. Tarr BD, Yalkowsky SH. (1989). Enhanced intestinal absorption of cyclosporine in rats through the reduction of emulsion droplet size. Pharm Res 6:40-3.
47. Veiga F, Fernandes C, Teixeira F. (2000). Oral bioavailability and hypoglycaemic activity of tolbutamide/cyclodextrin inclusion complexes. Int J Pharm 202:165-71.
48. Wagner SG. (1975). Fundamentals of clinical pharmacokinetics. Hamilton, IL: Drug Intelligence Publications Inc.
49. Wang D, Miller R, Zheng J, Hu C. (2000). Comparative population pharmacokinetic-pharmacodynamic analysis for piroxicam-beta-cyclodextrin and piroxicam. J Clin Pharmacol 40:1257-66.
50. Wang L, Dong J, Chen J, et al. (2009). Design and optimization of a new self-nanoemulsifying drug delivery system. J Colloid Interface Sci 330:443-8.
51. Yang Z, Lu A, Wong BC, et al. (2013). Effect of liposomes on the absorption of water-soluble active pharmaceutical ingredients via oral administration. Curr Pharm Des 19:6647-54.
52. Yeap YY, Trevaskis NL, Quach T, et al. (2013). Intestinal bile secretion promotes drug absorption from lipid colloidal phases via induction of supersaturation. Mol Pharm 10:1874-89.